High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer

Familial Cancer

Volumn 11, Issue 4, 2012, Pages 623-628

  Gaj, Pawel ^a   Kluska, Anna ^b   Nowakowska, Dorota ^b   Bałabas, Aneta ^b   Piątkowska, Magdalena ^b   Dabrowska, Michalina ^b   Niwińska, Anna ^b   Ostrowski, Jerzy ^a,b  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

BRCA1; BRCA2; Breast; Cancer; Familial; Mutations; Nonfamilial; Sporadic

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GENOMIC DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FOUNDER EFFECT; FOUNDER MUTATION; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NONFAMILIAL BREAST CANCER; ONSET AGE; POLAND; PRACTICE GUIDELINE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 84870460304     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-012-9560-4     Document Type: Article

References (22)

1. Wojciechowska U, Didkowska J, Zatoński W (2010) Cancer in Poland in 2008. 1-124. http://www.onkologia.org.pl/doc/Nowotwory2008.pdf
2. Ostrowski J, Wyrwicz LS (2009) Integrating genomics, proteomics and bioinformatics in translational studies of molecular medicine. Expert Rev Mol Diagn 9:623-630. doi:10.1586/erm. 09.41
3. Kenemans P, Verstraeten RA, Verheijen RHM (2004) Oncogenic pathways in hereditary and sporadic breast cancer. Maturitas 49:34-43. doi:10.1016/j. maturitas.2004.06.005 (Pubitemid 39209369)
4. Foulkes WD (2008) Inherited susceptibility to common cancers. N Engl J Med 359:2143-2153. doi:10.1056/NEJMra0802968
5. Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117-1130. doi:10.1086/375033 (Pubitemid 36530000)
6. Friedman E, Kotsopoulos J, Lubinski J, Lynch HT, Ghadirian P et al (2006) Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Res 8:R15. doi:10.1186/bcr1387 (Pubitemid 44377916)
7. Górski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J et al (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110:683-686. doi:10.1002/ijc.20162 (Pubitemid 38746026)
8. Brozek I, Cybulska C, Ratajska M, Piatkowska M, Kluska A et al (2011) Prevalence of the most frequent BRCA1 mutations in Polish population. J Appl Genet 52:325-330. doi:10.1007/s133 53-011-0040-6
9. Ferla R, Calò V, Cascio S, Rinaldi G, Badalamenti G et al (2007) Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 18(Suppl 6):vi93-vi98. doi:10.1093/annonc/mdm234
10. Trainer AH, Lewis CR, Tucker K, Meiser B, Friedlander M et al (2010) The role of BRCA mutation testing in determining breast cancer therapy. Nat Rev Clin Oncol 7:708-717. doi:10.1038/nrclinonc.2010.175
11. Brozek I, Ratajska M, Piatkowska M, Kluska A, Balabas A et al (2012) Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases. Fam Cancer 11:1-4. doi:10.1007/s10689- 012-9519-5
12. Turner NC, Reis-Filho JS (2006) Basal-like breast cancer and the BRCA1 phenotype. Oncogene 25:5846-5853. doi:10.1038/sj.onc. 1209876 (Pubitemid 44453440)
13. Tilanus-Linthorst M, Verhoog L, Obdeijn I-M, Bartels K, Menke-Pluymers M et al (2002) A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. Int J Cancer 102:91-95. doi:10.1002/ijc.10666
14. Warner E, Plewes DB, Shumak RS, Catzavelos GC, Di Prospero LS et al (2001) Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19: 3524-3531 (Pubitemid 32730090)
15. Go'rski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J et al (2000) Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 66:1963-1968. doi: 10.1086/302922 (Pubitemid 30480103)
16. Skasko E, Paszko Z, Niwińska A, Kwiatkowska E, Kruczek A et al (2004) The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives. Eur J Gynaecol Oncol 25:470-474 (Pubitemid 38954526)
17. Grzybowska E, Siemińska M, Zientek H, Kalinowska E, Michalska J et al (2002) Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population. Acta Biochim Pol 49:351-356 (Pubitemid 135686781)
18. Skasko E, Kluska A, Niwińska A, Kwiatkowska E, Bałabas A et al (2009) Age at onset of bilateral breast cancer, the presence of hereditary BRCA1, BRCA2, CHEK2 gene mutations and positive family history of cancer. Onkologie 32:182-188. doi: 10.1159/000200930
19. Balabas A, Skasko E, Nowakowska D, Niwinska A, Blecharz P (2010) Novel germline mutations in BRCA2 gene among breast and breast-ovarian cancer families from Poland. Fam Cancer 9:267-274. doi:10.1007/s10689-010-9338-5
20. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575. doi:10.1086/519795 (Pubitemid 47330214)
21. Gadzicki D, Evans DG, Harris H, Julian-Reynier C, Nippert I et al (2011) Genetic testing for familial/hereditary breast cancercomparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. J Community Genet 2:53-69. doi:10.1007/s12687-011-0042-4
22. Pharoah PDP, Antoniou A, Bobrow M, Zimmern RL, Easton DF et al (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33-36. doi:10.1038/ng853